Arixtra
Product Images NDC 54868-5501

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Arixtra (NDC 54868-5501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Arixtra 7.5 mg/0.6 mL Package Label (5501)

Label for ARIXTRA 7.5 mg/0.6 mL syringe distributed by Physicians Total Care, Inc. The label includes the NDC number 54868-5501-0, a 6 mL volume indication, lot number 0000, and an expiration date of 01/60. The manufacturer is listed as Glaxo Smith Kline.*

FDA Label Image

Image Of No Label Available (No Label)

FDA Label Image

Figure 1 (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 01)

Illustration showing the use of a syringe with a pre-attached needle cap removal process. One hand holds the syringe while the other hand pulls off the needle cap. An arrow and a circle highlight the action of removing the needle cap. The diagram is labeled as Figure 1.*

FDA Label Image

Figure 2 (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 02)

An instructional black-and-white illustration showing a person preparing to inject a medication into the abdominal area. The person’s hand is pinching the skin on the abdomen, holding a syringe or delivery device poised for injection. The image appears to demonstrate correct injection technique or site for a subcutaneous shot.*

FDA Label Image

Figure 3 (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 03)

An instructional illustration showing a hand administering a subcutaneous injection into the side of a patient's abdomen using a prefilled syringe labeled ARIXTRA. The image is labeled as Figure 3 and demonstrates proper injection technique.*

FDA Label Image

Figure 4 (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 04)

An instructional photograph showing the injection of a medication into an infant's foot. The image demonstrates proper needle placement and injection technique for subcutaneous administration in a small child, labeled as Figure 4.*

FDA Label Image

Fondaparinux Sodium Chemical Structure (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 05)

Chemical structure diagrams of the active ingredient in ARIXTRA, showing multiple sodium salt forms attached to a complex carbohydrate structure.*

FDA Label Image

Arixtra Safety Syringe (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 06)

Instructional illustration showing the assembly of a syringe device for ARIXTRA by Physicians Total Care, Inc. The diagram includes numbered parts of the syringe mechanism, highlighting components such as the plunger, barrel, and needle hub in sequence for proper use or preparation.*

FDA Label Image

Syringe Before Use (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 07)

An instructional illustration showing a syringe with numbered parts identified, including the plunger (2), the barrel or body (3), and the needle (4). The syringe appears to be a standard prefilled or injectable type device.*

FDA Label Image

Syringe After Use (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 08)

An instructional illustration depicting parts of a prefilled syringe labeled with numbers 2, 3, and 4. The syringe appears to be associated with the product ARIXTRA by Physicians Total Care, Inc., though no text about dosing or usage instructions is visible.*

FDA Label Image

Figure A (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 09)

An illustration of a woman seated on the floor with one leg extended and the other bent. She is injecting medication into her lower abdomen, demonstrating a self-administration technique. There are no product packaging or labels visible.*

FDA Label Image

Figure B (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 10)

An instructional illustration showing the steps to prepare an injection using a syringe and vial, including removing the cap and drawing fluid from the vial, depicted with directional arrows to guide the process.*

FDA Label Image

Figure C (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 11)

An anatomical illustration showing a person holding the lower abdominal area with two arrows indicating a specific region on the right side of the lower abdomen.*

FDA Label Image

Figure D (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 12)

An instructional illustration showing a person injecting medication into the abdominal area. The image demonstrates proper injection technique or site placement, focusing on the use of a syringe or pen for subcutaneous injection in the lower abdomen.*

FDA Label Image

Figure E (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 13)

An instructional illustration showing a hand holding a syringe labeled ARIXTRA. The image focuses on demonstrating an injection technique or syringe handling with an arrow pointing to a specific part of the syringe, indicating a step in preparing or administering the injection.*

FDA Label Image

Figure F (Cd7bea8f 5fc2 4e22 90b4 D91f4f59bff1 14)

An instructional image showing the use of a prefilled syringe for subcutaneous injection administration. The syringe is held in one hand with the cap being removed or the needle being prepared for injection, demonstrating the proper technique for delivering the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.